Re: Thoughts on ZCC
in response to
by
posted on
Sep 06, 2021 06:01AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
RVXOT, so can we conclude that ZCC holds no IPs as things stand presently? And ZCC only holds the RVX royalty preferred shares.
If so does this mean that OTC ZHCLF shares represent ZCC and not Zenith Epigenetics?
Koo